| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | Chief Technology Officer | Common Stock | 62.3K | $1.05M | $16.83 | Jan 6, 2025 | Direct |
| Cartesian Therapeutics, Inc. | Chief Technology Officer | Stock Option (Right to Buy) | 79.1K | $62.5K | $0.79 | Dec 10, 2024 | Direct |
| Cartesian Therapeutics, Inc. | Chief Technology Officer | Employee Stock Option (right to buy) | 47.4K | Jan 2, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RNAC | Cartesian Therapeutics, Inc. | Jan 3, 2025 | 2 | -$81.8K | 4 | Jan 7, 2025 | Chief Technology Officer |
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Chief Technology Officer |
| RNAC | Cartesian Therapeutics, Inc. | Dec 9, 2024 | 7 | -$326K | 4 | Dec 11, 2024 | Chief Technology Officer |
| RNAC | Cartesian Therapeutics, Inc. | Nov 19, 2024 | 10 | -$594K | 4 | Nov 21, 2024 | Chief Technology Officer |
| RNAC | Cartesian Therapeutics, Inc. | Nov 14, 2024 | 11 | -$1.32M | 4 | Nov 18, 2024 | Chief Technology Officer |
| RNAC | Cartesian Therapeutics, Inc. | Apr 8, 2024 | 6 | $0 | 4 | Apr 10, 2024 | Chief Technology Officer |
| RNAC | Cartesian Therapeutics, Inc. | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Chief Operating Officer |
| SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 3 | $0 | 4 | Nov 15, 2023 | Chief Operations Officer |
| SELB | Cartesian Therapeutics, Inc. | Nov 13, 2023 | 0 | $0 | 3 | Nov 15, 2023 | Chief Operations Officer |